Atrovent vs Wixela
What to choose Atrovent or Wixela
Atrovent is inhaler of type Rescue while Wixela is of Control type. Atrovent and Wixela are both brand inhalers. Atrovent is manufactured by pharmaceutical company Boehringer Ingelheim, while Wixela is manufactured by Viatris. The main substance of Atrovent is Ipratropium. The available dosage for Atrovent is 21 mcg. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50.
The average cost for Atrovent is around $365 per inhaler while average price for Wixela is around $240 per inhaler, said Baylor Scott, an Instructor at the Dakota Wesleyan University and a Medical Assistant at a clinic that uses Atrovent and Wixela.
Atrovent and Wixela Comparison
|Substance:||Ipratropium||Fluticasone + Salmeterol|